Olmesartan Medoxomilo + Hidroclorotiazida Blixie (Olmesartan Medoxomil, Hydrochlorothiazide)

Olmesartan medoxil combined with hydrochlorothiazide is used to manage high blood pressure by targeting the renin‑angiotensin‑aldosterone system and promoting diuresis.

• Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk.
• Resistant hypertension: provides additional blood‑pressure control when monotherapy is insufficient.
• Hypertension with fluid retention: combines ARB action with a thiazide diuretic to reduce volume overload.

• Olmesartan medoxil selectively blocks the angiotensin II type 1 (AT1) receptor, preventing angiotensin II‑mediated vasoconstriction and aldosterone release. Hydrochlorothiazide inhibits sodium‑chloride reabsorption in the distal convoluted tubule, increasing urinary excretion of sodium and water. The combined actions produce vasodilation and reduced plasma volume, resulting in lower arterial pressure.

Olmesartan medoxil with hydrochlorothiazide may cause a range of adverse reactions.

Common Side Effects

• Dizziness: light‑headed sensation, especially after standing.
• Headache: mild to moderate intensity.
• Fatigue: general feeling of tiredness.
• Increased urination: due to the diuretic component.
• Electrolyte imbalance: mild changes in potassium or sodium levels.

Serious or Rare Side Effects

• Severe hypotension: markedly low blood pressure causing fainting.
• Acute kidney injury: sudden decline in renal function.
• Hyperkalemia: elevated potassium levels that may affect heart rhythm.
• Allergic reactions: rash, itching, or swelling of the face and throat.
• Liver enzyme elevation: abnormal liver function test results.

When prescribing Olmesartan Medoxil + Hydrochlorothiazide, clinicians should consider several safety aspects.

• Renal function: assess baseline kidney function and monitor periodically.
• Electrolytes: check serum potassium and sodium before initiation and during therapy.
• Pregnancy: avoid use; drug is contraindicated in the second and third trimesters.
• Volume depletion: ensure patient is not dehydrated before starting therapy.
• Drug interactions: review concomitant medications for additive blood‑pressure effects.
• Store at ambient temperature: keep tablets in the original container, protect from moisture and direct sunlight.

Olmesartan Medoxil + Hydrochlorothiazide can interact with several medicines, requiring clinical awareness.

Major Interactions (Avoid)

• Aliskiren: combined use may cause excessive potassium loss and renal impairment.
• Lithium: risk of lithium toxicity due to reduced renal clearance.
• NSAIDs: may blunt antihypertensive effect and increase risk of kidney injury.

Moderate Interactions (Monitor Closely)

• ACE inhibitors or other ARBs: additive risk of hyperkalemia and renal dysfunction.
• Potassium‑sparing diuretics: may cause elevated potassium levels.
• Antidiabetic drugs: may enhance hypoglycaemic effect, requiring dose adjustment.